PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	Calmodulin
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Ovarian Cancer
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Anxiety
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Prostate Cancer
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Hyperglycemia
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Depression
4-1BB Ligand		Target	Disease	Multiple Myeloma
4-1BB Ligand		Target	Disease	Lung Carcinoma
4-1BB Ligand		Target	Target	ERK1
4-1BB Ligand		Target	Disease	Organ Transplantation
4-1BB Ligand		Target	Disease	Influenza
4-1BB Ligand		Target	Disease	Arthritis
4-1BB Ligand		Target	Disease	Leukemia
4-1BB Ligand		Target	Disease	Inflammation
4-1BB Ligand		Target	Target	CD34
4-1BB Ligand		Target	Disease	Asthma
4-1BB Ligand		Target	Disease	Breast Cancer
4-1BB Ligand		Target	Target	BTK
4-1BB Ligand		Target	Disease	Chronic Lymphocytic Leukemia
4-1BB Ligand		Target	Drug	Doxorubicin